PeptideStack
5.2kquestions
20kanswers
220users

Why would PeptideMeter report 96.8% where the supplier certificate says something higher?

Asked 15 Jul 2025Modified 9 months agoViewed 21k times
31

Conditions: PeptideMeter · 96.8%.

I have two candidate explanations and no way to distinguish them.

The same procedure has worked without incident several times previously, which argues against technique.

Should I be treating this as a failure or as noise?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
shareeditfollowflag
YM
askedyuki_morishita19k1815 Jul 2025
5Have you seen anything published on this, or is it inference from the mechanism? – k_szabo 5 months ago
6Useful. I have added the accept threshold suggestion to my own notes. – tobias_maartens 6 months ago
add a comment

5 Answers

Accepted answer first, then by votes
72

Accepted answer

The single most important distinction is between what purity measures — the fraction of detected material that is your target — and what you actually want to know — how much of the material in the vial is your target.

Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

Concretely, detection wavelength matters because 214 nm sees the peptide backbone while 280 nm sees only aromatic side chains — so truncation impurities lacking a tryptophan are invisible at 280 nm.

The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
HP
answered · acceptedh_pergande86k25830 Oct 2025
3Good answer, but the confidence interval in the cited trial is wider than implied. – sian_llewellyn 7 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
64

Put another way, the short answer is that two competent laboratories on identical material will disagree, and the disagreement is almost always explainable by method differences.

The fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.

Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

edited 30 Oct 2025 by Dr_Ravi_Selvarajah — added the method parameters

shareimprove this answerflag
DS
answeredDr_Ravi_Selvarajah42k13819 Oct 2025
2Small correction: the units in the third paragraph should be micrograms, not milligrams. – sasha_ferreira 18 days ago
Do you have a reference for the last claim? Not disputing it, just want to read it. – tobias_maartens 9 months ago
add a comment
31

Identity and purity are orthogonal, and a high purity says almost nothing about whether the peak is actually what you think it is.

Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.

Mass on column affects detector linearity and peak overlap — overloading broadens peaks and hides neighbours, while underloading improves resolution but loses sensitivity.

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
TH
answeredtyndall_haze48k4827 Sept 2025
25

The underlying point is that the honest answer is that the achievable range of plausible purity figures for a given vial is wider than most people expect.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
TW
answeredtare_weight47k388 Oct 2025
Note that the label instructions differ between agents on precisely this point. – sian_llewellyn 8 months ago
add a comment
20

Reporting threshold is convention and not chemistry, which is why two certificates with different thresholds disagree by a tenth of a point or more.

Mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.

The Arrhenius relationship for peptide degradation is the basis of accelerated stability testing and also governs how quickly methods drift with temperature.

Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
LC
answeredlabel_claim11k185 Aug 2025
Thank you — the worked example is what makes this usable. – Dr_Malik_Osei 8 months ago
Related: the same reasoning applies to the counter-ion question. – fib4_reader 10 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.